Phio Pharmaceuticals Other Long Term Liabilities (Quarterly) Analysis

Phio Pharmaceuticals Corp. (PHIO)

1.18 -0.01 (-0.84%) USD | NASDAQ | Jan 13, 16:00

1.13 -0.05 (-4.24%) Pre-Market: 20:00

View Other Long Term Liabilities (Quarterly) for PHIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Tharimmune, Inc.	--
NovaBay Pharmaceuticals, Inc.	--
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	Upgrade
Oragenics, Inc.	--